Lead optimization of an acylhydrazone scaffold possessing antiviral activity against Lassa virus |
| |
Authors: | James R Burgeson Dima N Gharaibeh Amy L Moore Ryan A Larson Sean M Amberg Tove’ C Bolken Dennis E Hruby Dongcheng Dai |
| |
Institution: | SIGA Technologies, Inc., 4575 SW Research Way, Suite 230, Corvallis, OR 97333, United States |
| |
Abstract: | Previously we reported the optimization of antiviral scaffolds containing benzimidazole and related heterocycles possessing activity against a variety of arenaviruses. These series of compounds were discovered through an HTS campaign of a 400,000 small molecule library using lentivirus-based pseudotypes incorporated with the Lassa virus envelope glycoprotein (LASV GP). This screening also uncovered an alternate series of very potent arenavirus inhibitors based upon an acylhydrazone scaffold. Subsequent SAR analysis of this chemical series involved various substitutions throughout the chemical framework along with assessment of the preferred stereochemistry. These studies led to an optimized analog (ST-161) possessing subnanomolar activity against LASV and submicromolar activity against a number of other viruses in the Arenaviridae family. |
| |
Keywords: | Lassa fever Lassa virus Arenavirus SAR Antiviral |
本文献已被 ScienceDirect 等数据库收录! |